|
|
||||||||
Laboratory of Infectious Diseases, Building 7, Room 100, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, U.S.A.
The complete nucleotide sequence of the P+C mRNA of human parainfluenza virus type 3 (PF3) was determined by sequencing cDNA, viral genomic RNA and mRNA. The P+C mRNA is 2009 nucleotides in length, exclusive of poly(A), and contains two overlapping open reading frames (ORFs). The P+C mRNA encodes two proteins, the 602 amino acid nucleocapsid phosphoprotein P and the 199 amino acid non-structural protein C. Peptide mapping confirmed that the two proteins are unrelated. Hybridarrest translation experiments assigned each of the two proteins to its respective ORF. These studies showed that the coding strategy of the PF3 P+C mRNA is similar to that of Sendai virus. Amino acid sequence alignment showed that the P and C proteins of PF3 and Sendai virus represent homologous pairs. However, these homologies are represented by high contents of accepted amino acid substitutions and by similarity in hydropathy profiles rather than by high contents of exact amino acid matches. Homology with the P and C proteins of measles, canine distemper and respiratory syncytial viruses was at the threshold of significance. The patterns of amino acid sequence homology among the paramyxovirus HN, F, NP, P and C proteins are compared.
Keywords: parainfluenza virus type 3, sequence, phosphoprotein
Received 16 June 1986;
accepted 28 August 1986.
This article has been cited by other articles:
![]() |
F. Momose, T. Naito, K. Yano, S. Sugimoto, Y. Morikawa, and K. Nagata Identification of Hsp90 as a Stimulatory Host Factor Involved in Influenza Virus RNA Synthesis J. Biol. Chem., November 15, 2002; 277(47): 45306 - 45314. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tao, A. P. Durbin, S. S. Whitehead, F. Davoodi, P. L. Collins, and B. R. Murphy Recovery of a Fully Viable Chimeric Human Parainfluenza Virus (PIV) Type 3 in Which the Hemagglutinin-Neuraminidase and Fusion Glycoproteins Have Been Replaced by Those of PIV Type 1 J. Virol., April 1, 1998; 72(4): 2955 - 2961. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |